Skip To Main Content
Ying Lu on Muck Rack

Ying Lu

As seen in: Color Research & Application, Nature, Wiley, Wiley Online Library, arXiv, Memory Studies, PLOS, PLOS Biology, PLOS Medicine, ScienceDirect and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ying

Contact Ying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

CLEC4G deficiency aggravates cholestatic liver fibrosis through impaired angiocrine signaling

|
By Yahui Li, Shicheng Peng, Hong Zhao, Ying Lu, Bo Wu, Wei Cai, Jun Wang, Yongtao Xiao, Xinbei Tian
| Nature Verified
Abstract CLEC4G is a C-type lectin receptor predominantly expressed in liver sinusoidal endothelial cells (LSECs), with its expression markedly downregulated in cirrhotic livers. However, its specific role in cholestatic liver injury and fibrosis remains largely unexplored. Here we show that CLEC4G expression is reduced in cholestatic livers from children with biliary atresia (BA) and in bile duct ligation (BDL) -treated mice.
Open in Who Shared Issue with article?

How to Test an MT5 Market Demo Before Renting an Indicator or EA

|
By Ying Lu
| mql5.com
Downloading a free demo is useful only when the test answers practical questions. Does the panel load on the broker's symbol? Are its states understandable? Does it fail safely when history is missing? For an Expert Advisor, can you see the complete order lifecycle and risk controls before considering a rental? This checklist explains how to review an MQL5 Market product in the MetaTrader 5 Strategy Tester without sharing a trading-account password or attaching a paid-product demo to a live chart.
Open in Who Shared Issue with article?

GLP-1 Receptor Agonists and Risk of Skin Cancer in Adults With Type 2 Diabetes: A Target Trial Emulation

|
By Huilin Tang, Bingyu Zhang, Ying Lu
| Wiley Online Library Verified
1 Introduction Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are used widely for the management of type 2 diabetes (T2D) and, increasingly, obesity [1, 2]. Several GLP-1RAs have demonstrated cardiovascular and renal protective effects, and their role in metabolic disease treatment continues to expand [3]. As prescribing volumes increase, evaluating their long-term safety profile is essential.
Open in Who Shared Issue with article?
See all 277 licensed articles (364 Total)